1,763 results · 16ms · Sources: EU EUDAMED, US FDA

A113 Anti-HBc IgM

Device
EU IVDD · Eu Ivd General ·LGC Clinical Diagnostics, Inc.·On the market

A115 Anti-HBc IgG

Device
EU IVDD · Eu Ivd General ·LGC Clinical Diagnostics, Inc.·On the market

HAEMOGLOBIN SUBTYPES HBA2, HBC, HBF, HBS, ETC.(EXCL. HBA1)

Device
EU IVDD · Eu Ivd General ·Seleo S.r.l.·On the market·11 countries

HAEMOGLOBIN SUBTYPES HBA2, HBC, HBF, HBS, ETC.(EXCL. HBA1)

Device
EU IVDD · Eu Ivd General ·Seleo S.r.l.·On the market·11 countries

HAEMOGLOBIN SUBTYPES HBA2, HBC, HBF, HBS, ETC.(EXCL. HBA1)

Device
EU IVDD · Eu Ivd General ·Seleo S.r.l.·On the market·11 countries

HAEMOGLOBIN SUBTYPES HBA2, HBC, HBF, HBS, ETC.(EXCL. HBA1)

Device
EU IVDD · Eu Ivd General ·Seleo S.r.l.·On the market·11 countries

ACCURUN 119 Anti-Hepatitis B e Antigen (Anti-HBe) Positive Control

Device
EU IVDD · Eu Ivd General ·LGC Clinical Diagnostics, Inc.·On the market

IRTA1 (QM005)

Device
EU IVDD · Eu Ivd General ·biocyc Biotechnologie GmbH & Co. KG·On the market

Inhibin alpha (QR088)

Device
EU IVDD · Eu Ivd General ·biocyc Biotechnologie GmbH & Co. KG·On the market

Inhibin alpha (QR088)

Device
EU IVDD · Eu Ivd General ·biocyc Biotechnologie GmbH & Co. KG·On the market

Inhibin alpha (QR088)

Device
EU IVDD · Eu Ivd General ·biocyc Biotechnologie GmbH & Co. KG·On the market

Inhibin alpha (QR088)

Device
EU IVDD · Eu Ivd General ·biocyc Biotechnologie GmbH & Co. KG·On the market

Inhibin alpha (QR088)

Device
EU IVDD · Eu Ivd General ·biocyc Biotechnologie GmbH & Co. KG·On the market

Inhibin alpha (QR088)

Device
EU IVDD · Eu Ivd General ·biocyc Biotechnologie GmbH & Co. KG·On the market

Inhibin alpha (QR088)

Device
EU IVDD · Eu Ivd General ·biocyc Biotechnologie GmbH & Co. KG·On the market

IgG4 (QR092)

Device
EU IVDD · Eu Ivd General ·biocyc Biotechnologie GmbH & Co. KG·On the market

IgG4 (QR092)

Device
EU IVDD · Eu Ivd General ·biocyc Biotechnologie GmbH & Co. KG·On the market

IgG4 (QR092)

Device
EU IVDD · Eu Ivd General ·biocyc Biotechnologie GmbH & Co. KG·On the market

IgG4 (QR092)

Device
EU IVDD · Eu Ivd General ·biocyc Biotechnologie GmbH & Co. KG·On the market

IgG4 (QR092)

Device
EU IVDD · Eu Ivd General ·biocyc Biotechnologie GmbH & Co. KG·On the market